International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Université Paris Cité, Hôpital Saint-Louis, Peter MacCallum Cancer Centre, The University of Melbourne, Wroclaw Medical University, Medical University of Lodz, AZ Sint-Jan, Samsung Medical Center, CancerCare Manitoba, National Health Service, Barts Health NHS Trust, Princess Margaret Cancer Centre, Ospedale Santa Maria della Misericordia di Udine, Centre Hospitalier Universitaire de Toulouse, Alberta Hospital Edmonton, University of Alberta Hospital, Hospital Universitario Central de Asturias, University Hospital Leipzig, Istituto Oncologico Romagnolo, Hospital Universitario Virgen del Rocío, Essen University Hospital, Harvard University, Dana-Farber Cancer Institute, University Hospital Ulm